Mark L. Gonzalgo, M.D., Ph.D.
Urologic Oncology/Robotic Surgery, University of Miami
Dr. Mark Gonzalgo is a board-certified and fellowship-trainedwith expertise in the treatment of urologic cancers. Dr. Gonzalgo was recruited to the University of Miami from Stanford where he served as Director of Robotic-Assisted Urologic Cancer and was one of the most experienced urologic oncologists on the west coast specializing in robotic for , bladder, and kidney cancer. He was previously on faculty at Johns Hopkins where he was Associate Professor of Urology and Director of the Fellowship Program in Urologic Oncology at The Brady Urological Institute.
He received his undergraduate degree with honors from the University of California at Berkeley and completed medical and graduate school at the USC Keck School of Medicine. Dr. Gonzalgo completed his generaland urology training at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center. Dr. Gonzalgo is a recognized expert in DNA methylation and is particularly interested in developing new diagnostic and therapeutic approaches for cancer detection and treatment. He has carried out pioneering research on the molecular biology and early detection of , bladder, and kidney cancer and has published extensively on the scientific and clinical aspects of these diseases. Dr. Gonzalgo has been recognized as a Top Doctor by U.S. News & World Report.
Click here for more information.